Stock Events

Seres Therapeutics (MCRB) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Next
-0.5
-0.36
-0.22
-0.07

Details

Expected EPS
-0.07455
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

Seres Therapeutics (MCRB) will report earnings of for Q4 2024 on November 06, 2024.

0 Comments

Share your thoughts